Use of drug-killed cancer cells: A method to assess the therapeutic effectiveness of immunogenic cell death
Methods in Cell Biology · 2025
DOI: 10.1016/bs.mcb.2024.10.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Cell Biology, 2025. Verfasst von Kenny Misael Calvillo-Rodriguez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Inmunologia y Virologia, Facultad de Ciencias Biologicas, Universidad Autónoma de Nuevo Leon, San Nicolás de los Garza, Nuevo León, Me…. Hauptthemen laut MEDLINE: Immunogenic Cell Death, Neoplasms, Immunotherapy. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías.
Abstract (Originalsprache)
Cancer immunotherapy has revolutionized cancer treatment by harnessing the immune system's potential to combat cancer. Among the various strategies in this field, the use of killed tumor cells (KC) induced by immunogenic cell death (ICD) inducers has gained attraction. This approach involves the treatment of cancer cells in vitro, followed by the subcutaneous injection of these killed cells into tumor-bearing mice. ICD induction triggers the exposure and release of damage-associated molecular patterns (DAMPs) and neoantigens, activating both innate and adaptive immune responses against cancer. Vaccination assays with immunocompetent mice and syngeneic cancer cells are considered the gold standard for identifying ICD inductors, as they effectively demonstrate the immunized host's capacity to achieve tumor rejection, typically showing more than 50% of protection. Despite significant progress in understanding ICD mechanisms, translating these findings into clinical practice faces challenges. Controversially, some reports indicate ICD induction with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Inmunologia y Virologia, Facultad de Ciencias Biologicas, Universidad Autónoma de Nuevo Leon, San Nicolás de los Garza, Nuevo León, Mexico. Electronic address: kenny.misaelcr@gmail.com.
- Laboratorio de Inmunologia y Virologia, Facultad de Ciencias Biologicas, Universidad Autónoma de Nuevo Leon, San Nicolás de los Garza, Nuevo León, Mexico; Tecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Cent…
- Laboratorio de Inmunologia y Virologia, Facultad de Ciencias Biologicas, Universidad Autónoma de Nuevo Leon, San Nicolás de los Garza, Nuevo León, Mexico.
- Tecnologico de Monterrey, Escuela de Ingenieria y Ciencias, Centro de Biotecnologia-FEMSA, Monterreey, Nuevo León, Mexico; Tecnologico de Monterrey, Institute for Obesity Research, Monterrey, Nuevo León, Mexico.
- Laboratorio de Inmunologia y Virologia, Facultad de Ciencias Biologicas, Universidad Autónoma de Nuevo Leon, San Nicolás de los Garza, Nuevo León, Mexico. Electronic address: ana.martinezto@uanl.edu.mx.
Förderung
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
Zitieren
APA
Calvillo-Rodriguez, K. M., Gonzalez-Flores, M. N., Tamez-Guerra, R., Rodriguez-Padilla, C., Antunes-Ricardo, M., & Martinez-Torres, A. C. (2025). Use of drug-killed cancer cells: A method to assess the therapeutic effectiveness of immunogenic cell death. Methods in Cell Biology. https://doi.org/10.1016/bs.mcb.2024.10.012
Vancouver
Calvillo-Rodriguez KM, Gonzalez-Flores MN, Tamez-Guerra R, Rodriguez-Padilla C, Antunes-Ricardo M, Martinez-Torres AC. Use of drug-killed cancer cells: A method to assess the therapeutic effectiveness of immunogenic cell death. Methods in Cell Biology. 2025. doi:10.1016/bs.mcb.2024.10.012
BibTeX
@article{CalvilloRodriguez2025,
author = {Calvillo-Rodriguez, Kenny Misael and Gonzalez-Flores, Maria Norma and Tamez-Guerra, Reyes and Rodriguez-Padilla, Cristina and Antunes-Ricardo, Marilena and Martinez-Torres, Ana Carolina},
title = {Use of drug-killed cancer cells: A method to assess the therapeutic effectiveness of immunogenic cell death},
journal = {Methods in Cell Biology},
year = {2025},
doi = {10.1016/bs.mcb.2024.10.012}
}
EUVIMED